Bank Of New York Mellon Corp Axsome Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

$521 Trillion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$58.39 - $75.0 $7.31 Million - $9.38 Million	125,116 New	125,116 $7.72 Billion
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $5.13 Million - $10.2 Million	128,498 New	128,498 $9.91 Million
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $638,983 - $1.24 Million	17,720 Added 15.09%	135,130 $6.03 Million
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $260,597 - $560,392	11,987 Added 11.37%	117,410 $4.5 Million
Q1 2022 May 11, 2022	SELL	$23.7 - $41.39 $392,377 - $685,252	-16,556 Reduced 13.57%	105,423 $4.36 Million

Q4 2021 Feb 11, 2022	SELL	$30.7 - $43.36 $749,908 - $1.06 Million	-24,427 Reduced 16.68%	121,979 $4.61 Million
Q3 2021 Nov 12, 2021	BUY	$19.91 - $68.26 $161,410 - $553,383	8,107 Added 5.86%	146,406 $4.83 Million
Q2 2021 Aug 11, 2021	SELL	$50.63 - $73.5 $337,955 - $490,612	-6,675 Reduced 4.6%	138,299 $9.33 Million
Q1 2021 May 13, 2021	SELL	$55.91 - $81.44 $304,429 - $443,440	-5,445 Reduced 3.62%	144,974 $8.21 Million
Q4 2020 Feb 09, 2021	BUY	$66.31 - $86.52 $123,336 - $160,927	1,860 Added 1.25%	150,419 $12.3 Million
Q3 2020 Nov 12, 2020	BUY	$68.34 - $85.84 $103,876 - $130,476	1,520 Added 1.03%	148,559 $10.6 Million
Q2 2020 Aug 12, 2020	SELL	$49.87 - $98.69 $306,301 - $606,153	-6,142 Reduced 4.01%	147,039 $12.1 Million
Q1 2020 May 06, 2020	BUY	$41.2 - $101.31 $270,107 - $664,188	6,556 Added 4.47%	153,181 $9.01 Million
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $297,872 - $1.89 Million	-17,826 Reduced 10.84%	146,625 $15.2 Million
Q3 2019 Nov 07, 2019	BUY	$20.24 - $29.16 $1,113 - $1,603	55 Added 0.03%	164,451 $3.33 Million
Q2 2019 Aug 12, 2019	BUY	$13.46 - $25.75 $1.03 Million - $1.97 Million	76,555 Added 87.15%	164,396 $4.23 Million
Q1 2019 May 14, 2019	BUY	$2.63 - $16.34 $139,787 - $868,487	53,151 Added 153.22%	87,841 $1.25 Million
Q4 2018 Feb 11, 2019	BUY	$2.0 - $4.15 $69,380 - $143,963	34,690 New	34,690 $98,000

Others Institutions Holding AXSM

# of Institutions

290

Shares Held

37.1M

Call Options Held

401K

Put Options Held

464K

Rtw Investments, LP New York, NY

4.49M
Shares

$355 Million
5.75% of portfolio
Vanguard Group Inc Valley Forge, PA

3.74M
Shares

$295 Million
0.01% of portfolio
Black Rock Inc. New York, NY

3.2M
Shares

$252 Million
0.01% of portfolio
Fairmount Funds Management LLC Philadelphia, PA

2.36M
Shares

$186 Million
30.01% of portfolio
Deep Track Capital, LP Greenwich, CT

1.3M
Shares

$103 Million
3.44% of portfolio

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.38B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account